|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options (Right to Buy) | $ 106.59 | (2) | 08/18/2023 | Common Stock | 14,114 | 14,114 | D | ||||||||
Stock Options (Right to Buy) | $ 106.59 | (3) | 08/18/2023 | Common Stock | 18,819 | 18,819 | D | ||||||||
Restricted Stock Units | (1) | (4) | (4) | Common Stock | 2,174 | 2,174 | D | ||||||||
Stock Options (Right to Buy) | $ 125.05 | (4) | 08/09/2024 | Common Stock | 11,982 | 11,982 | D | ||||||||
Stock Options (Right to Buy) | $ 125.05 | (5) | 08/09/2024 | Common Stock | 15,976 | 15,976 | D | ||||||||
Restricted Stock Units | (1) | (6) | (6) | Common Stock | 2,537 | 2,537 | D | ||||||||
Stock Options (Right to Buy) | $ 177.32 | (6) | 08/08/2025 | Common Stock | 13,550 | 13,550 | D | ||||||||
Stock Options (Right to Buy) | $ 177.32 | (7) | 08/08/2025 | Common Stock | 18,066 | 18,066 | D | ||||||||
Restricted Stock Units | (1) | (8) | (8) | Common Stock | 3,151 | 3,151 | D | ||||||||
Stock Options (Right to Buy) | $ 190.41 | (8) | 08/07/2026 | Common Stock | 15,948 | 15,948 | D | ||||||||
Stock Options (Right to Buy) | $ 190.41 | (9) | 08/07/2026 | Common Stock | 21,265 | 21,265 | D | ||||||||
Restricted Stock Units | (1) | 08/05/2020 | A | 2,575 | (10) | (10) | Common Stock | 2,575 | $ 0 | 2,575 | D | ||||
Stock Options (Right to Buy) | $ 267.87 | 08/05/2020 | A | 11,488 | (10) | 08/05/2027 | Common Stock | 11,488 | $ 0 | 11,488 | D | ||||
Stock Options (Right to Buy) | $ 267.87 | 08/05/2020 | A | 15,318 | (11) | 08/05/2027 | Common Stock | 15,318 | $ 0 | 15,318 | D | ||||
Stock Options (Right to Buy) | $ 267.87 | 08/05/2020 | A | 24,975 | (12) | 08/05/2027 | Common Stock | 24,975 | $ 0 | 24,975 | D | ||||
Stock Options (Right to Buy) | $ 267.87 | 08/05/2020 | A | 24,975.00 | (13) | 08/05/2027 | Common Stock | 24,975.00 | $ 0 | 24,975.00 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Eansor Norman David 8100 SOUTHPARK WAY, A-8 LITTLETON, CO 80120 |
President-Protein Sciences |
/s/ Brenda S. Furlow as Attorney-in-Fact for N. David Eansor pursuant to Power of Attorney previously filed. | 08/07/2020 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. |
(2) | Fully exercisable. |
(3) | Options to purchase 4,705 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 4,704 shares vest on 8/18/2020. |
(4) | Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
(5) | Options to purchase 3,994 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021. |
(6) | Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
(7) | Options to purchase 4,517 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 4,516 shares vest on each of 8/8/2021 and 8/8/2022. |
(8) | Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
(9) | Options to purchase 5,317 shares vest on 8/7/2020 and options to purchase 5,316 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023. |
(10) | Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
(11) | Options to purchase 3,830 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 3,829 shares vest on each of 8/5/2023 and 8/5/2024. |
(12) | Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021 |
(13) | Options to purchase 8,325 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023. |